Cystic Fibrosis Clinical Trials

2 clinical trials found for Cystic Fibrosis.

Pipeline by Phase

PhaseTrialsDistribution
Phase 2 1
50%
N/A 1
50%

Trial Status Breakdown

Trials for Cystic Fibrosis

A Clinical Trial to Evaluate the Long-term Safety and Durability of Efficacy of BI 3720931, an Inhaled Lentiviral Vector Gene Therapy, After Single Dose Administration in a Previous Clinical Trial, in People With Cystic Fibrosis Rolled-over From a Previous Clinical Trial With BI 3720931 (Lenticlair™-ON)

NCT06962852 · ACTIVE NOT RECRUITING · Phase 2

Role of Genetic Factors in the Pathogenesis of Lung Disease

NCT00001532 · RECRUITING · N/A

Frequently Asked Questions

What clinical trials are available for Cystic Fibrosis?

There are 2 clinical trials listed for Cystic Fibrosis. These span various phases from early safety studies to post-approval monitoring. Browse the trial listings below for details.

How do I find recruiting Cystic Fibrosis trials?

Look for trials with "Recruiting" status in the listings below, or visit our recruiting page to filter by condition. Each trial page includes decoded eligibility criteria to help you determine if you qualify.

What phases are Cystic Fibrosis trials in?

Current Cystic Fibrosis trials are distributed across: Phase 2 (1), N/A (1).

Find More Trials